Factors affecting the tuberculosis risk in patients receiving anti-tumor necrosis factor-α treatment.


Borekci S. , Atahan E., Yilmaz D. D. , Mazican N. , Duman B., Ozguler Y. , ...More

Respiration; international review of thoracic diseases, vol.90, no.3, pp.191-8, 2015 (Journal Indexed in SCI Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 90 Issue: 3
  • Publication Date: 2015
  • Doi Number: 10.1159/000434684
  • Title of Journal : Respiration; international review of thoracic diseases
  • Page Numbers: pp.191-8
  • Keywords: Tumor necrosis factor-alpha inhibitors, Tuberculosis, Risk factors, RHEUMATOID-ARTHRITIS, PULMONARY TUBERCULOSIS, FACTOR ANTAGONISTS, FACTOR INHIBITORS, THERAPY, TNF, AGENTS, SURVEILLANCE, INFLIXIMAB, DISEASES

Abstract

Background: Tumor necrosis factor (TNF)-alpha inhibitors are known to increase the risk of tuberculosis (TB). Objectives: To examine the factors associated with an increased risk of TB in patients receiving anti-TNF-alpha treatment (aTNF-alpha-T).